These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25938303)

  • 1. Safety and Procedural Success of Left Atrial Appendage Exclusion With the Lariat Device: A Systematic Review of Published Reports and Analytic Review of the FDA MAUDE Database.
    Chatterjee S; Herrmann HC; Wilensky RL; Hirshfeld J; McCormick D; Frankel DS; Yeh RW; Armstrong EJ; Kumbhani DJ; Giri J
    JAMA Intern Med; 2015 Jul; 175(7):1104-9. PubMed ID: 25938303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
    Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage ligation with the next generation LARIAT(+) suture delivery device: Early clinical experience.
    Bartus K; Gafoor S; Tschopp D; Foran JP; Tilz R; Wong T; Lakkireddy D; Sievert H; Lee RJ
    Int J Cardiol; 2016 Jul; 215():244-7. PubMed ID: 27128539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation.
    Stone D; Byrne T; Pershad A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):121-7. PubMed ID: 23765504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LARIAT or AtriClip: Complications Profile and Comparison in Patients with Atrial Fibrillations Based on Manufacturer and User Facility Device Experience Database.
    Litwinowicz R; Batko J; Rusinek J; Olejek W; Rams D; Kowalewski M; Bartuś K; Burysz M
    Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138158
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of multimodality imaging in percutaneous left atrial appendage suture ligation with the LARIAT device.
    Laura DM; Chinitz LA; Aizer A; Holmes DS; Benenstein R; Freedberg RS; Kim EE; Saric M
    J Am Soc Echocardiogr; 2014 Jul; 27(7):699-708. PubMed ID: 24874974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience.
    Bartus K; Han FT; Bednarek J; Myc J; Kapelak B; Sadowski J; Lelakowski J; Bartus S; Yakubov SJ; Lee RJ
    J Am Coll Cardiol; 2013 Jul; 62(2):108-118. PubMed ID: 23062528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes from real-world experience of left atrial appendage exclusion with LARIAT device.
    Parikh V; Bartus K; Litwinowicz R; Turagam MK; Sadowski J; Kapelak B; Bartus M; Podolec J; Brzezinski M; Musat D; Rasekh A; Mittal S; Cheng J; Badhwar N; Lee R; Lakkireddy D
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2849-2857. PubMed ID: 31596044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAUDE Database Analysis of Post-Approval Outcomes following Left Atrial Appendage Closure with the Watchman Device.
    Ledesma PA; Uzomah UA; Yu X; Shaqdan A; Khaloo P; Galvin J; Mansour M; Ptaszek LM; Ruskin JN
    Am J Cardiol; 2021 Aug; 152():78-87. PubMed ID: 34116792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Events After Left Atrial Appendage Closure: Lessons Learned From the Manufacturer and User Facility Device Experience (MAUDE) Database.
    Heaton J; Okoh AK; Sossou C; Singh S; Sandhu M; Chakrabarti R; Rao R; Waxman S; Tayal R; Wasty N
    J Invasive Cardiol; 2020 Aug; 32(8):E216-E218. PubMed ID: 32737269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusion of electrical and mechanical function of the left atrial appendage in patients with persistent atrial fibrillation: differences in efficacy and safety between endocardial ablation vs epicardial LARIAT ligation (the EXCLUDE LAA study).
    Parikh V; Rasekh A; Mohanty S; Yarlagadda B; Atkins D; Bommana S; Turagam M; Jeffery C; Carroll H; Nydegger C; Jaeger M; Dar T; Cheng J; Gopinnathanair R; Dibiase L; Lee R; Horton R; Natale A; Lakkireddy D
    J Interv Card Electrophysiol; 2020 Apr; 57(3):409-416. PubMed ID: 31863251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A collective European experience with left atrial appendage suture ligation using the LARIAT+ device.
    Tilz RR; Fink T; Bartus K; Wong T; Vogler J; Nentwich K; Panniker S; Fang Q; Piorkowski C; Liosis S; Gaspar T; Sawan N; Metzner A; Nietlispach F; Maisano F; Lee RJ; Foran JP; Ouyang F; Sievert H; Deneke T; Kuck KH
    Europace; 2020 Jun; 22(6):924-931. PubMed ID: 32044994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation.
    Lakkireddy D; Afzal MR; Lee RJ; Nagaraj H; Tschopp D; Gidney B; Ellis C; Altman E; Lee B; Kar S; Bhadwar N; Sanchez M; Gadiyaram V; Evonich R; Rasekh A; Cheng J; Cuoco F; Chandhok S; Gunda S; Reddy M; Atkins D; Bommana S; Cuculich P; Gibson D; Nath J; Ferrell R; Matthew E; Wilber D
    Heart Rhythm; 2016 May; 13(5):1030-1036. PubMed ID: 26872554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of left atrial appendage closure using an epicardial suture snaring device: Systematic review and current status.
    Sabzwari SRA; Mehta NA; Garg L; Racharla L; Kurtz E; Afzal MR; Turagam MK; Lakkireddy D
    J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2189-2198. PubMed ID: 34164881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of acute hyponatremia following LARIAT ligation of the left atrial appendage.
    Holmes BB; Patel N; Lugo R; Richardson T; Metawee M; Rinke LL; Meisch C; Shoemaker MB; Ellis CR
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2501-2507. PubMed ID: 31515883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.
    Massumi A; Chelu MG; Nazeri A; May SA; Afshar-Kharaghan H; Saeed M; Razavi M; Rasekh A
    Am J Cardiol; 2013 Mar; 111(6):869-73. PubMed ID: 23312129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term outcomes of epicardial left atrial appendage ligation with the second-generation LARIAT device: a high-volume electrophysiology center experience.
    Fink T; Schlüter M; Tilz RR; Heeger CH; Lemes C; Maurer T; Reissmann B; Rottner L; Santoro F; Mathew S; Rillig A; Ouyang F; Kuck KH; Metzner A
    Clin Res Cardiol; 2018 Dec; 107(12):1139-1147. PubMed ID: 29881879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of compassionate use of LARIAT® device for epicardial ligation of anatomically complex left atrial appendages.
    Patel MB; Rasekh A; Shuraih M; Chelu MG; Bartlett T; Mathuria N; Naeini P; Strickland J; Massumi A; Razavi M; Cheng J
    J Interv Card Electrophysiol; 2015 Jan; 42(1):11-9. PubMed ID: 25595627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of closed-chest ligation of the left atrial appendage in humans.
    Bartus K; Bednarek J; Myc J; Kapelak B; Sadowski J; Lelakowski J; Yakubov SJ; Lee RJ
    Heart Rhythm; 2011 Feb; 8(2):188-93. PubMed ID: 21050893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.